| Booklet: What You Need to Know about
Multiple Myeloma |
![[National Cancer Institute Logo]](../../images/ncilogo_nobar.gif) |
|
|
Treatment Methods
Plasmacytoma and multiple myeloma are very hard to cure. Although
patients who have a plasmacytoma may be free of symptoms for a long time
after treatment, many eventually develop multiple myeloma. For those who
have multiple myeloma, treatment can improve the quality of a patient's life
by controlling the symptoms and complications of the disease.
People who have multiple myeloma but do not have symptoms of the disease
usually do not receive treatment. For these patients, the risks and side
effects of treatment are likely to outweigh the possible benefits. However,
these patients are watched closely, and they begin treatment when symptoms
appear. Patients who need treatment for multiple myeloma usually receive chemotherapy
and sometimes radiation therapy.
Chemotherapy is the use of drugs to treat cancer. It is the main
treatment for multiple myeloma. Doctors may prescribe two or more drugs that
work together to kill myeloma cells. Many of these drugs are taken by mouth;
others are injected into a blood vessel. Either way, the drugs travel
through the bloodstream, reaching myeloma cells all over the body. For this
reason, chemotherapy is called systemic
therapy.
Anticancer drugs often are given in cycles--a treatment period followed
by a rest period, then another treatment and rest period, and so on. Most
patients take their chemotherapy at home, as outpatients at the hospital, or
at the doctor's office. However, depending on their health and the drugs
being given, patients may need to stay in the hospital during treatment.
Radiation therapy (also called radiotherapy) uses high-energy rays to
damage cancer cells and stop them from growing. In this form of treatment, a
large machine aims the rays at a tumor and the area close to it. Treatment
with radiation is local therapy; it
affects only the cells in the treated area.
Radiation therapy is the main treatment for people who have a single
plasmacytoma. They usually receive radiation therapy every weekday for 4 to
5 weeks in the outpatient department of a hospital or clinic.
People who have multiple myeloma sometimes receive radiation therapy in
addition to chemotherapy. The purpose of the radiation therapy is to help
control the growth of tumors in the bones and relieve the pain that these
tumors cause. Treatment usually lasts for 1 to 2 weeks.
<<
Back
Content Page
Next >>
|